Researchers have developed an oxygen-releasing bioink that may be useful in 3D printing bioengineered cell constructs.
Since mid-2019, the Fraunhofer IBMT has been developing an analysis platform as an alternative to animal experiments in drug development.
New muscle has successfully been created in mice using a minimally invasive technique dubbed ‘intravital 3D bioprinting’.
An anaesthesia team used 3D printing and virtual reality to produce an exact model of the airway of a 7-year-old girl in order to prepare properly for an operation to remove part of her lung.
Researchers developed a device that can monitor bladder volume in real time and effectively empty the bladder.
For the first time, researchers managed to make intact human organs transparent. Using microscopic imaging they could revealed underlying complex structures of the see-through organs at the cellular level.
Researchers have found a way to speed up tissue engineering for potential organ regeneration or replacement using a novel bioprinter.
Researchers report that among patients with obesity, robotic kidney transplants produce survival outcomes comparable to those seen among nonobese patients.
A robotic single-port kidney transplant, which enables all surgical instruments and the donor kidney to be placed through one small abdominal incision.
Researchers have shown that AI can evaluate written messages by patients with severely diseased livers to detect language abnormalities associated with liver disease.
Researchers have announced a collaboration to 3D bioprint stem-cell tissue that could one day be used to treat end-stage kidney disease.
Researchers have 3D printed an artificial cornea using the bioink which is made of decellularized corneal stroma and stem cells.
A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body.